Serum/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells

Oncogene

Volumn 30, Issue 28, 2011, Pages 3198-3206

  Fagerli, U M ^a,b   Ullrich, K ^c,d   Stuhmer T ^e   Holien, T ^a   Kochert K ^c,d   Holt, R U ^a   Bruland, O ^f   Chatterjee, M ^e   Nogai, H ^c   Lenz, G ^c   Shaughnessy Jr , J D ^g   Mathas, S ^c,d   Sundan, A ^a   Bargou, R C ^e   Dorken B ^c,d   Borset M ^a,b   Janz, M ^c,d  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^e UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^f HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^g UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

cytokines; multiple myeloma; SGK1; STAT3

Indexed keywords

CYCLIN DEPENDENT KINASE 6; CYTOKINE; INTERLEUKIN 21; INTERLEUKIN 6; JANUS KINASE; PROTEIN P130; PROTEIN P21; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; SHORT HAIRPIN RNA; STAT PROTEIN; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BONE MARROW CELL; CANCER GROWTH; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; MYELOMA CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE;

BONE MARROW CELLS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CYTOKINES; DOWN-REGULATION; HUMANS; IMMEDIATE-EARLY PROTEINS; JANUS KINASES; MULTIPLE MYELOMA; PROTEIN-SERINE-THREONINE KINASES; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC;

EID: 79960359868     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.79     Document Type: Article

References (22)

1. Brocke-Heidrich K, Kretzschmar AK, Pfeifer G, Henze C, Löffler D, Koczan D et al. (2004). Interleukin-6-dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 familyindependent survival pathway closely associated with Stat3 activation. Blood 103: 242-251. (Pubitemid 38029945)
2. Brunet A, Park J, Tran H, Hu LS, Hemmings BA, Greenberg ME. (2001). Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol Cell Biol 21: 952-965. (Pubitemid 32104742)
3. Catlett-Falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R et al. (1999). Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 10: 105-115. (Pubitemid 29077388)
4. Chatterjee M, Stühmer T, Herrmann P, Bommert K, Dörken B, Bargou RC. (2004). Combined disruption of both the MEK/ERK and the IL-6R/STAT3 pathways is required to induce apoptosis of multiple myeloma cells in the presence of bone marrow stromal cells. Blood 104: 3712-3721. (Pubitemid 39564449)
5. Hideshima T, Mitsiades C, Tonon G, Richardson PG, Anderson KC. (2007). Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets. Nat Rev Cancer 7: 585-598. (Pubitemid 47106630)
6. Hideshima T, Nakamura N, Chauhan D, Anderson KC. (2001). Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma. Oncogene 20: 5991-6000. (Pubitemid 32955041)
7. Hsu J, Shi Y, Krajewski S, Renner S, Fisher M, Reed JC et al. (2001). The AKT kinase is activated in multiple myeloma tumor cells. Blood 98: 2853-2855.
8. Kobayashi T, Cohen P. (1999). Activation of serum- and glucocorticoidregulated protein kinase by agonists that activate phosphatidylinositide 3-kinase is mediated by 3-phosphoinositide-dependent protein kinase-1 (PDK1) and PDK2. Biochem J 339 (Part 2): 319-328. (Pubitemid 29209961)
9. Leong ML, Maiyar AC, Kim B, OKeeffe BA, Firestone GL. (2003). Expression of the serum- and glucocorticoid-inducible protein kinase, Sgk, is a cell survival response to multiple types of environmental stress stimuli in mammary epithelial cells. J Biol Chem 278: 5871-5882. (Pubitemid 36800834)
10. Meng F, Yamagiwa Y, Taffetani S, Han J, Patel T. (2005). IL-6 activates serum and glucocorticoid kinase via p38alpha mitogenactivated protein kinase pathway. Am J Physiol Cell Physiol 289: C971-C981. (Pubitemid 41361652)
11. Ocio EM, Mateos MV, Maiso P, Pandiella A, San-Miguel JF. (2008). New drugs in multiple myeloma: mechanisms of action and phase I/II clinical findings. Lancet Oncol 9: 1157-1165.
12. Ogata A, Chauhan D, Urashima M, Teoh G, Treon SP, Anderson KC. (1997). Blockade of mitogen-activated protein kinase cascade signaling in interleukin 6-independent multiple myeloma cells. Clin Cancer Res 3: 1017-1022. (Pubitemid 27253011)
13. Park J, Leong ML, Buse P, Maiyar AC, Firestone GL, Hemmings BA. (1999). Serum and glucocorticoid-inducible kinase (SGK) is a target of the PI 3-kinase-stimulated signaling pathway. EMBO J 18: 3024-3033. (Pubitemid 29255611)
14. Podar K, Chauhan D, Anderson KC. (2009). Bone marrow microenvironment and the identification of new targets for myeloma therapy. Leukemia 23: 10-24.
15. Sahoo S, Brickley DR, Kocherginsky M, Conzen SD. (2005). Coordinate expression of the PI3-kinase downstream effectors serum and glucocorticoid- induced kinase (SGK-1) and Akt-1 in human breast cancer. Eur J Cancer 41: 2754-2759. (Pubitemid 41607569)
16. Shanmugam I, Cheng G, Terranova PF, Thrasher JB, Thomas CP, Li B. (2007). Serum/glucocorticoid-induced protein kinase-1 facilitates androgen receptor-dependent cell survival. Cell Death Differ 14: 2085-2094. (Pubitemid 350131158)
17. Tu Y, Gardner A, Lichtenstein A. (2000). The phosphatidylinositol 3- kinase/AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses. Cancer Res 60: 6763-6770.
18. van Zaanen HC, Lokhorst HM, Aarden LA, Rensink HJ, Warnaar SO, van der Lelie J et al. (1998). Chimaeric anti-interleukin 6 monoclonal antibodies in the treatment of advanced multiple myeloma: a phase I dose-escalating study. Br J Haematol 102: 783-790. (Pubitemid 28387063)
19. Vasudevan KM, Barbie DA, Davies MA, Rabinovsky R, McNear CJ, Kim JJ et al. (2009). AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer. Cancer Cell 16: 21-32.
20. Webster MK, Goya L, Ge Y, Maiyar AC, Firestone GL. (1993). Characterization of sgk, a novel member of the serine/threonine protein kinase gene family which is transcriptionally induced by glucocorticoids and serum. Mol Cell Biol 13: 2031-2040. (Pubitemid 23097682)
21. Wu W, Chaudhuri S, Brickley DR, Pang D, Karrison T, Conzen SD. (2004). Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells. Cancer Res 64: 1757-1764. (Pubitemid 38428699)
22. Zöllinger A, Stühmer T, Chatterjee M, Gattenlöhner S, Haralambieva E, Müller-Hermelink HK et al. 2008 Combined functional and molecular analysis of tumor cell signaling defines 2 distinct myeloma subgroups: Akt-dependent and Akt-independent multiple myeloma. Blood 112: 3403-3411.